This important study, which tackles the challenge of analyzing genome integrity and instability in unicellular pathogens by introducing a novel single-cell genomics approach, presents compelling ...

Abstract: Nanofluids are potential liquids that enhance the thermophysical characteristics and the ability to transport heat rather than base liquids. This article discusses the non-isothermal heat ...

Thermo Fisher Scientific, already a big player in providing services to the biopharmaceutical industry, is adding to its technology capabilities with the $9 billion acquisition of clinical trial ...

Thermo Fisher Scientific is breaking out the big bills to score a clinical research treat. With $8.875 billion in cash, the life science giant is adding Clario Holdings to its goodie bag, the company ...

Oct 29 (Reuters) - Thermo Fisher (TMO.N), opens new tab said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, strengthening its clinical trial research ...

Notably, Clario centralizes clinical trial endpoint data from devices, sites and patients, allowing pharma and biotech companies to digitally collect, manage, and analyze evidence across all phases of ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a definitive agreement to acquire Clario Holdings, Inc., a leading ...

Thermo Fisher Scientific has reached a definitive agreement to acquire clinical trial endpoint data solutions provider Clario Holdings for $8.875bn in cash upon completion of the deal. Clario will be ...

Thermo Fisher Scientific stock has rebounded strongly as tariff and policy fears proved overstated, with shares up 30% since the prior low. Thermo raised 2025 revenue and EPS guidance, driven by sales ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s proven growth ...